Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Managing COVID-19 alone can be a difficult in many cases, but for persons with pre-existing conditions such as diabetes the challenge can be all the greater, and specific considerations need to be taken when prescribing treatment to manage them. This book is a culmination of scientific work driven by personal conviction to enhance the care provided to the vulnerable populations COVID-19 patients with diabetes. It spans topics from the epidemiology and predictors of complications and increased mortality in COVID-19, to in-depth discussion of the pathophysiology of the disease. Pathophysiology…mehr
Managing COVID-19 alone can be a difficult in many cases, but for persons with pre-existing conditions such as diabetes the challenge can be all the greater, and specific considerations need to be taken when prescribing treatment to manage them. This book is a culmination of scientific work driven by personal conviction to enhance the care provided to the vulnerable populations COVID-19 patients with diabetes. It spans topics from the epidemiology and predictors of complications and increased mortality in COVID-19, to in-depth discussion of the pathophysiology of the disease. Pathophysiology of COVID-19 is addressed comprehensively as common soil pathogenetic pathways, and by organ system such as the lung, the kidney and most pertinently for diabetes, the diabetic foot ulcers and diabetes co-morbidities. A multi-disciplinary approach was needed to manage these complex patients; thus, the authors represent a variety of disciplines including pharmacology, endocrinology, nephrology,infectious diseases, podiatry, vascular surgery, pulmonary/critical care, and general medicine. Written by experts in the field, Diabetes and COVID-19: Considerations and Clinical Management is a blueprint for treatment of patients with both conditions.
Alyson K. Myers, MD, Division of Endocrinology, Department of Medicine, Montefiore Einstein, Bronx, NY
Inhaltsangabe
COVID-19: epidemiology, etiology, clinical manifestations, diagnosis, therapeutic options, and prevention.- Pathophysiology: How COVID-19 Impacts the Pancreas and Peripheral Insulin Resistance.- Risk of COVID-19 in Persons with Diabetes.- Pathophysiology of Lung Dysfunction in Diabetes.- Diabetic kidney disease and COVID-19.- The Impact of COVID-19 on Diabetic Foot Ulcers.- Co-morbid obesity and its impact on diabetes and COVID-19.- Overview of Inpatient Mgt of Diabetes and COVID 19.- Management of critically ill persons with COVID-19 and diabetes.- Managing Outpatient Diabetes in Persons with COVID-19 and Diabetes.- The Use of Diabetes Technology In Persons With Diabetes and Coronavirus 2019 (COVID-19).- COVID-19 Vaccination in Persons with Diabetes.- COVID-19 Vaccination in Persons with Diabetes.- Long-haul COVID Symptoms in Person with Diabetes.
COVID-19: epidemiology, etiology, clinical manifestations, diagnosis, therapeutic options, and prevention.- Pathophysiology: How COVID-19 Impacts the Pancreas and Peripheral Insulin Resistance.- Risk of COVID-19 in Persons with Diabetes.- Pathophysiology of Lung Dysfunction in Diabetes.- Diabetic kidney disease and COVID-19.- The Impact of COVID-19 on Diabetic Foot Ulcers.- Co-morbid obesity and its impact on diabetes and COVID-19.- Overview of Inpatient Mgt of Diabetes and COVID 19.- Management of critically ill persons with COVID-19 and diabetes.- Managing Outpatient Diabetes in Persons with COVID-19 and Diabetes.- The Use of Diabetes Technology In Persons With Diabetes and Coronavirus 2019 (COVID-19).- COVID-19 Vaccination in Persons with Diabetes.- COVID-19 Vaccination in Persons with Diabetes.- Long-haul COVID Symptoms in Person with Diabetes.
COVID-19: epidemiology, etiology, clinical manifestations, diagnosis, therapeutic options, and prevention.- Pathophysiology: How COVID-19 Impacts the Pancreas and Peripheral Insulin Resistance.- Risk of COVID-19 in Persons with Diabetes.- Pathophysiology of Lung Dysfunction in Diabetes.- Diabetic kidney disease and COVID-19.- The Impact of COVID-19 on Diabetic Foot Ulcers.- Co-morbid obesity and its impact on diabetes and COVID-19.- Overview of Inpatient Mgt of Diabetes and COVID 19.- Management of critically ill persons with COVID-19 and diabetes.- Managing Outpatient Diabetes in Persons with COVID-19 and Diabetes.- The Use of Diabetes Technology In Persons With Diabetes and Coronavirus 2019 (COVID-19).- COVID-19 Vaccination in Persons with Diabetes.- COVID-19 Vaccination in Persons with Diabetes.- Long-haul COVID Symptoms in Person with Diabetes.
COVID-19: epidemiology, etiology, clinical manifestations, diagnosis, therapeutic options, and prevention.- Pathophysiology: How COVID-19 Impacts the Pancreas and Peripheral Insulin Resistance.- Risk of COVID-19 in Persons with Diabetes.- Pathophysiology of Lung Dysfunction in Diabetes.- Diabetic kidney disease and COVID-19.- The Impact of COVID-19 on Diabetic Foot Ulcers.- Co-morbid obesity and its impact on diabetes and COVID-19.- Overview of Inpatient Mgt of Diabetes and COVID 19.- Management of critically ill persons with COVID-19 and diabetes.- Managing Outpatient Diabetes in Persons with COVID-19 and Diabetes.- The Use of Diabetes Technology In Persons With Diabetes and Coronavirus 2019 (COVID-19).- COVID-19 Vaccination in Persons with Diabetes.- COVID-19 Vaccination in Persons with Diabetes.- Long-haul COVID Symptoms in Person with Diabetes.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/neu